Conical cornea is a kind of congenital corneal lesion. Due to biomechanical changes, the affected cornea swells forward, and irregular astigmatism occurs, which may cause corneal clouding, photophobia and tearing in severe cases. It has long been believed that corneal transplantation is the only option. In my medical experience, I have seen many such patients who underwent corneal transplantation, but although the eyeballs were saved, the postoperative symptoms of astigmatism and immune rejection led to the patients’ pain, further vision loss, and also increased the patients’ financial burden. In fact, some patients can have good vision for a long time by wearing rigid corneal contact lenses prior to corneal transplantation. There are at least two other options, the first of which is corneal cross-linking, a procedure that strengthens the cornea by administering vitamin B2 to the surface of the cornea and then applying specially designed ultraviolet light, a procedure that has been performed in Europe for 50 years, and has been undergoing a three-year clinical trial in the United States, with approval by the Food and Drug Administration’s FDA expected in 2012. According to published data, the procedure has an 80 percent control rate for mild to moderate conical corneas. The results are clear. In addition, corneal stromal ring placement can be performed for severe conical corneas. Some patients were also controlled. Therefore, when treating patients with cone corneas, we have many of the above options before corneal transplantation, and perhaps they will end up avoiding corneal transplantation!